SCHEMBL7154990

SCHEMBL7154990

COc1ccccc1NS(=O)(=O)CSc1nc2ccccc2s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
HSD17B10 Q99714 1/20 0.49
POLB P06746 2/20 0.49
HTT P42858 2/20 0.47
PKM P14618 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
MAPK1 P28482 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
HIF1A Q16665 1/20 0.47
MAPT P10636 3/20 0.46
PTGS2 P35354 1/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 2/20 0.46
APEX1 P27695 2/20 0.45
RECQL P46063 1/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7149622 0.89 ALDH1A1 (0.59) ALDH1A1HSD17B10POLBHTTPKM
SCHEMBL7144785 0.88 MEN1 (0.42) ALDH1A1HSD17B10POLBHTTSMN1; SMN2
SCHEMBL7153200 0.88 MAPT (0.55) ALDH1A1HTTSMN1; SMN2MAPK1L3MBTL1
SCHEMBL7148781 0.87 ALDH1A1 (0.54) ALDH1A1HSD17B10POLBHTTSMN1; SMN2
SCHEMBL7149211 0.86 ALDH1A1 (0.53) ALDH1A1HSD17B10POLBHTTSMN1; SMN2
SCHEMBL7147603 0.85 LMNA (0.57) ALDH1A1HSD17B10POLBHTTSMN1; SMN2
SCHEMBL7154367 0.82 L3MBTL1 (0.55) ALDH1A1HSD17B10POLBPKMSMN1; SMN2
SCHEMBL7144781 0.81 MAPT (0.52) ALDH1A1HSD17B10POLBHTTPKM
SCHEMBL7149130 0.78 MAPT (0.53) ALDH1A1HSD17B10POLBHTTSMN1; SMN2
SCHEMBL7152177 0.78 ALDH1A1 (0.46) ALDH1A1HSD17B10POLBHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642263-B2 Antitumor agents, sulfided benzothiazole derivative containing sulfonamide ICONIX PHARMACEUTICALS INC. 2003-11-04 US disclosed
US-20030176474-A1 Modulators of Rho C activity ICONIX BIOSCIENCES, INC. 2003-09-18 US disclosed
WO-2003043577-A2 MODULATORS OF RHO C ACTIVITY ICONIX PHARMACEUTICALS, INC. (US) 2003-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176474-A1 Modulators of Rho C activity RHOC, ARHGDIA, ROCK1 ALDH1A1 2919/4885HSD17B10 2088/4885POLB 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.